Increased clearance of reactive aldehydes and damaged proteins in hypertension-induced compensated cardiac hypertrophy: Impact of exercise training

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Campos, Juliane Cruz ^a   Fernandes, Tiago ^a   Bechara, Luiz Roberto Grassmann ^a   Paixaõ, Nathalie Alves Da ^a   Brum, Patricia Chakur ^a   Oliveira, Edilamar Menezes De ^a   Ferreira, Julio Cesar Batista ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDES; BLOOD PRESSURE; CATALYST ACTIVITY; CELL DEATH; LIPIDS; OXIDATION; OXIDATIVE STRESS; PATHOLOGY; PROTEINS; QUALITY CONTROL; RATS;

ALDEHYDE DEHYDROGENASE; CARDIAC HYPERTROPHY; DELETERIOUS EFFECTS; EXERCISE TRAINING; LIPID PEROXIDATION; PROTEIN QUALITY CONTROL; SPONTANEOUSLY HYPERTENSIVE RATS; VENTRICULAR FUNCTIONS;

HEART;

ALDEHYDE; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; CHAPERONE; PROTEASOME; PROTEIN; ALDH2 PROTEIN, RAT; MITOCHONDRIAL PROTEIN;

AEROBIC EXERCISE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; DEPRESSED BLOOD PRESSURE; HEART FAILURE; HEART VENTRICLE FUNCTION; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; PROTEIN QUALITY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SWIMMING POOL; ANIMAL; BLOOD PRESSURE; CARDIOMEGALY; COMPLICATION; HEART RATE; METABOLISM; PROTEIN CARBONYLATION;

RATTUS;

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL; ALDEHYDES; ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; HEART RATE; HYPERTENSION; LIPID PEROXIDATION; MALE; MITOCHONDRIAL PROTEINS; PHYSICAL CONDITIONING, ANIMAL; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN CARBONYLATION; RATS; RATS, INBRED SHR;

EID: 84928978372     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/464195     Document Type: Article

References (39)

1. P. A. Heidenreich, J. G. Trogdon, O. A. Khavjou et al. , "Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association, " Circulation, vol. 123, no. 8, pp. 933-944, 2011.
2. Y. Kokubo and K. Kamide, "High-normal blood pressure and the risk of cardiovascular disease, " Circulation Journal, vol. 73, no. 8, pp. 1381-1385, 2009.
3. J. Déz, "Arterial hypertension in patients with heart failure, " Heart Failure Clinics, vol. 10, no. 2, pp. 233-242, 2014.
4. J. C. B. Ferreira, P. C. Brum, andD. Mochly-Rosen, "IIPKCand PKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure, " Journal ofMolecular andCellular Cardiology, vol. 51, no. 4, pp. 479-484, 2011.
5. J. C. B. Ferreira, T. Koyanagi, S. S. Palaniyandi et al. , "Pharmacological inhibition of IIPKC is cardioprotective in late-stage hypertrophy, " Journal ofMolecular and Cellular Cardiology, vol. 51, no. 6, pp. 980-987, 2011.
6. X. Wang and J. Robbins, "Heart failure and protein quality control, " Circulation Research, vol. 99, no. 12, pp. 1315-1328, 2006.
7. E. N. Churchill, J. C. Ferreira, P. C. Brum, L. I. Szweda, and D. Mochly-Rosen, "Ischaemic preconditioning improves proteasomal activity and increases the degradation of PKC during reperfusion, " Cardiovascular Research, vol. 85, no. 2, pp. 385-394, 2010.
8. J. C. Ferreira, B. N. Boer, M. Grinberg, P. C. Brum, and D. Mochly-Rosen, "Protein quality control disruption by PKCII in heart failure; rescue by the selective PKCII inhibitor, IIV5-3, " PLoS ONE, vol. 7, no. 3, Article ID e33175, 2012.
9. K. M. Gomes, J. C. Campos, L. R. Bechara et al. , "Aldehydedehydrogenase 2 activation in heart failure restores mitochondrial function and improves ventricular function and remodelling, " Cardiovascular Research, vol. 103, no. 4, pp. 498-508, 2014.
10. K. M. S. Gomes, L. R. Bechara, V. M. Lima et al. , "Aldehydic load and aldehyde dehydrogenase 2 profile during the progression of post-myocardial infarction cardiomyopathy: benefits of Alda-1, " International Journal of Cardiology, vol. 179, pp. 129-138, 2015.
11. C.-H. Chen, G. R. Budas, E. N. Churchill, M.-H. Disatnik, T. D. Hurley, and D. Mochly-Rosen, "Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart, " Science, vol. 321, no. 5895, pp. 1493-1495, 2008.
12. L. Farout, J. Mary, J. Vinh, L. I. Szweda, and B. Friguet, "Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes, " Archives of Biochemistry and Biophysics, vol. 453, no. 1, pp. 135-142, 2006.
13. D. C. Lee, R. R. Pate, C. J. Lavie, X. Sui, T. S. Church, and S. N. Blair, "Leisure-time running reduces all-cause and cardiovascular mortality risk, " Journal of the American College of Cardiology, vol. 64, no. 5, pp. 472-481, 2014.
14. C. Chrysohoou, A. Angelis, G. Tsitsinakis et al. , "Cardiovascular effects of high-intensity interval aerobic training combined with strength exercise in patients with chronic heart failure. A randomized phase III clinical trial, " International Journal of Cardiology, vol. 179, pp. 269-274, 2014.
15. T. Fernandes, F. C. Magalhães, F. R. Roque, M. I. Phillips, and E. M. Oliveira, "Exercise training prevents the microvascular rarefaction in hypertension balancing angiogenic and apoptotic factors: role of microRNAs-16,-21, and-126, " Hypertension, vol. 59, no. 2, pp. 513-520, 2012.
16. J. C. Campos, B. B. Queliconi, P. M. M. Dourado et al. , "Exercise training restores cardiac protein quality control in heart failure, " PLoS ONE, vol. 7, no. 12, Article IDe52764, 2012.
17. T. Fernandes, J. S. Nakamuta, F. C. Magalhães et al. , "Exercise training restores the endothelial progenitor cells number and function in hypertension: implications for angiogenesis, " Journal of Hypertension, vol. 30, no. 11, pp. 2133-2143, 2012.
18. J. C. B. Ferreira, N. P. L. Rolim, J. B. Bartholomeu, C. A. Gobatto, E. Kokubun, and P. C. Brum, "Maximal lactate steady state in running mice: effect of exercise training, " Clinical and Experimental Pharmacology and Physiology, vol. 34, no. 8, pp. 760-765, 2007.
19. C. Johns, I. Gavras, D. E. Handy, A. Salomao, and H. Gavras, "Models of experimental hypertension in mice, " Hypertension, vol. 28, no. 6, pp. 1064-1069, 1996.
20. M. Hermes-Lima, W. G. Willmore, and K. B. Storey, "Quantification of lipid peroxidation in tissue extracts based on Fe(III)xylenol orange complex formation, " Free Radical Biology and Medicine, vol. 19, no. 3, pp. 271-280, 1995.
21. L. Sun, J. C. B. Ferreira, and D. Mochly-Rosen, "ALDH2 activator inhibits increased myocardial infarction injury by nitroglycerin tolerance, " Science Translational Medicine, vol. 3, no. 107, Article ID 107ra111, 2011.
22. J. C. Campos, K. M. S. Gomes, and J. C. B. Ferreira, "Impact of exercise training on redox signaling in cardiovascular diseases, " Food and Chemical Toxicology, vol. 62, pp. 107-119, 2013.
23. J. M. Pfeffer, M. A. Pfeffer, M. C. Fishbein, and E. D. Frohlich, "Cardiac function and morphology with aging in the spontaneously hypertensive rat, " The American Journal of Physiology, vol. 237, no. 4, pp. H461-H468, 1979.
24. C. D. Garciarena, O. A. Pinilla, M. B. Nolly et al. , "Endurance training in the spontaneously hypertensive rat conversion of pathological into physiological cardiac hypertrophy, " Hypertension, vol. 53, no. 4, pp. 708-714, 2009.
25. M. A. Pfeffer, J. M. Pfeffer, and E. D. Frohlich, "Pumping ability of the hypertrophying left ventricle of the spontaneously hypertensive rat, " Circulation Research, vol. 38, no. 5, pp. 423-429, 1976.
26. F. Guéraud, M. Atalay, N. Bresgen et al. , "Chemistry and biochemistry of lipid peroxidation products, " Free Radical Research, vol. 44, no. 10, pp. 1098-1124, 2010.
27. C. Cuspidi, C. Sala, F. Negri, G. Mancia, and A. Morganti, "Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies, " Journal of Human Hypertension, vol. 26, no. 6, pp. 343-349, 2012.
28. C. Depre, Q. Wang, L. Yan et al. , "Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy, " Circulation, vol. 114, no. 17, pp. 1821-1828, 2006.
29. S. Li, X. Wang, Y. Li, C. K. Kost, D. S. Martin, and M. Bader, "Bortezomib, a proteasome inhibitor, attenuates angiotensin II-induced hypertension and aortic remodeling in rats, " PLoS ONE, vol. 8, no. 10, Article IDe78564, 2013.
30. Y. Ma, B. Chen, D. Liu et al. , "MG132 treatment attenuates cardiac remodeling and dysfunction following aortic banding in rats via the NF-B/TGF1 pathway, " Biochemical Pharmacology, vol. 81, no. 10, pp. 1228-1236, 2011.
31. M. Tang, J. Li, W. Huang et al. , "Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotesmaladaptive remodelling of stressed mouse hearts, " Cardiovascular Research, vol. 88, no. 3, pp. 424-433, 2010.
32. M. Sandri and J. Robbins, "Proteotoxicity: An underappreciated pathology in cardiac disease, " Journal of Molecular and Cellular Cardiology, vol. 71, pp. 3-10, 2014.
33. Y. Yang, R. Sharma, A. Sharma, S. Awasthi, and Y. C. Awasthi, "Lipid peroxidation and cell cycle signaling: 4-Hydroxynonenal, a key molecule in stress mediated signaling, " Acta Biochimica Polonica, vol. 50, no. 2, pp. 319-336, 2003.
34. D. S. Backos, K. S. Fritz, J. R. Roede, D. R. Petersen, and C. C. Franklin, "Posttranslational modification and regulation of glutamate-cysteine ligase by the ,-unsaturated aldehyde 4-hydroxy-2-nonenal, " Free Radical Biology andMedicine, vol. 50, no. 1, pp. 14-26, 2011.
35. C.-H. Chen, L. Sun, and D. Mochly-Rosen, "Mitochondrial aldehyde dehydrogenase and cardiac diseases, " Cardiovascular Research, vol. 88, no. 1, pp. 51-57, 2010.
36. J. C. B. Ferreira and D. Mochly-Rosen, "Nitroglycerin use in myocardial infarction patients: risks and benefits, " Circulation Journal, vol. 76, no. 1, pp. 15-21, 2012.
37. F. R. Roque, A. M. Briones, A. B. Garcá-Redondo et al. , "Aerobic exercise reduces oxidative stress and improves vascular changes of small mesenteric and coronary arteries in hypertension, " British Journal of Pharmacology, vol. 168, no. 3, pp. 686-703, 2013.
38. D. L. Feairheller, M. D. Brown, J.-Y. Park et al. , "Exercise training, NADPH oxidase p22phox gene polymorphisms, and hypertension, " Medicine and Science in Sports and Exercise, vol. 41, no. 7, pp. 1421-1428, 2009.
39. K. Husain, "Physical conditioning modulates rat cardiac vascular endothelial growth factor gene expression in nitric oxidedeficient hypertension, " Biochemical and Biophysical Research Communications, vol. 320, no. 4, pp. 1169-1174, 2004.